Separating viruses from saliva with sound waves for therapeutic studies

PressPacs

FOR IMMEDIATE RELEASE

“Acoustofluidic Virus Isolation via Bessel Beam Excitation Separation Technology”
ACS Nano

Developing antiviral therapeutics and vaccines requires close study of the viruses that cause disease. But how can these small germs be isolated from complex biological samples like saliva? Researchers in ACS Nano describe a platform that uses sound waves as acoustic tweezers to sort viruses from other compounds in a liquid. In demonstrations, the method quickly and accurately separates viruses from large and small particles in human saliva samples. 

A computer-generated image of four green coronaviruses.
Researchers use acoustic tweezers to pluck out coronaviruses from saliva samples in a new lab-on-a-chip device that could help scientists study viral diseases.
abu_zena/ Shutterstock.com

Isolating, identifying and genetically sequencing a virus provides important information to scientists about how it causes disease and how to develop effective therapeutics. Current methods for separating viruses from other particles in biological samples include time-consuming ultracentrifugation and cell culture procedures. To speed up and simplify the process, Luke Lee and Tony Jun Huang looked to acoustofluidics: a technology that uses sound waves to sort particles by size in a liquid. They chose a specific type of sound wave, called a Bessel beam, because it can be tuned to sort specific nanosized particles, and multiple waves remain tightly focused over long distances — like a pair of tweezers.  

The Bessel beam excitation separation technology (BEST) platform that Lee, Huang and colleagues developed consists of a rectangular chip with a sample-loading inlet at one end and separate virus and waste outlets at the other end. Two acoustic Bessel beams were applied across the chip, perpendicular to the sample flow. By tuning the beams’ wavelengths, the system sorted particles of different sizes:

  • Large particles larger than 150 nanometers (nm) in diameter were trapped on the chip.
  • Small particles smaller than 50 nm left through the waste outlet.
  • Viruses of intermediate sizes (50 to 150 nm) were collected via the virus outlet.

The team tested the BEST platform on human saliva samples loaded with SARS-CoV-2. Liquid collected from the chip’s virus outlet contained 90% of viral genetic material, while liquid from the waste outlet contained no viral genetic material, showing that the platform successfully isolated the virus. The researchers confirmed the results with electron microscopy, finding viruses only in liquid sampled from the virus outlet. Although BEST cannot yet separate waste particles from viruses that are smaller than 50 nm, such as parvoviruses, the researchers are working to broaden the technology’s range to enable its use in developing new therapeutic targets for numerous viral diseases. 

The authors acknowledge funding from the National Institutes of Health, National Science Foundation (NSF) and NSF Graduate Research Fellowship Program.

Some authors have competing financial interests in Ascent Bio-Nano Technologies Inc., to commercialize technologies involving acoustofluidics and acoustic tweezers, and equity in Liquid Diagnostics.

###

The American Chemical Society (ACS) is a nonprofit organization chartered by the U.S. Congress. ACS’ mission is to advance the broader chemistry enterprise and its practitioners for the benefit of Earth and all its people. The Society is a global leader in promoting excellence in science education and providing access to chemistry-related information and research through its multiple research solutions, peer-reviewed journals, scientific conferences, e-books and weekly news periodical Chemical & Engineering News. ACS journals are among the most cited, most trusted and most read within the scientific literature; however, ACS itself does not conduct chemical research. As a leader in scientific information solutions, its CAS division partners with global innovators to accelerate breakthroughs by curating, connecting and analyzing the world’s scientific knowledge. ACS’ main offices are in Washington, D.C., and Columbus, Ohio.

Registered journalists can subscribe to the ACS journalist news portal on EurekAlert! to access embargoed and public science press releases. For media inquiries, contact newsroom@acs.org.

Note: ACS does not conduct research but publishes and publicizes peer-reviewed scientific studies.

Media Contact

ACS Newsroom
newsroom@acs.org

Related Content